Nome Químico: 4-[4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone ; 4-[-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
Sorrisos: OC1(C2=CC=C(Cl)C=C2)CC[N+](CCCC(C3=CC=C(F)C=C3)=O)([O-])CC1
Inchi: InChI=1S/C21H23ClFNO2/c22-17-9-7-16(8-10-17)21(26)11-14-24(15-12-21)13-3-6-20(25)18-4-1-2-5-19(18)23/h1-2,4-5,7-10,26H,3,6,11-15H2
Spectrophotometric determination of haloperidol in pharmaceutical formulations
By Venkateswarlu, D.; Sreedevi, G.; Chakravarthy, I. E.; Rami Reddy, N.
From World Journal of Pharmaceutical Research (2020), 9(3), 764-769
Development and validation of RP-HPLC method for the simultaneous estimation of haloperidol and trihexyphenidyl in API and combined tablet dosage form
By Amulya, E.; Kumar, N. Naveen; Mounika, CH.; Kowmudi, V.; Supriya, N.; Madhuri, K. Ramya
From International Journal of Applied Pharmaceutical Sciences and Research (2018), 3(3), 36-40